Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease.

Παρόμοια τεκμήρια

• Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.
  ανά: Dahl-Puustinen, M L, κ.ά.
  Έκδοση: (1990)
• Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.
  ανά: Atiba, J O, κ.ά.
  Έκδοση: (1989)
• Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms.
  ανά: Dahl, M L, κ.ά.
  Έκδοση: (1994)
• Lack of effect of chloroquine on the debrisoquine (CYP2D6) and S-mephenytoin (CYP2C19) hydroxylation phenotypes
  ανά: MASIMIREMBWA, COLLEN M., κ.ά.
  Έκδοση: (1996)
• Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.
  ανά: Lennard, M S, κ.ά.
  Έκδοση: (1982)